Cannabis finance news

Cannabiz and Prohibition Partners join forces to launch Oceania report

by Martin Lane November 14, 2023April 30, 2024

Cannabiz has joined forces with Prohibition Partners to bring the cannabis data and intelligence firm’s Oceania […]

Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health

by Martin Lane November 14, 2023April 30, 2024

Medlab CEO to acquire tech IP after external deals fail to progress

by Steve Jones November 10, 2023April 30, 2024

Dragonfly listing stalls after ASX indicates it will reject application

by Steve Jones November 9, 2023November 9, 2023

Cannatrek reports A$14.5m profit as revenues double

by Steve Jones November 9, 2023November 9, 2023

Company news: MediCann Health; MGC Pharma; Bod Science

by Martin Lane November 8, 2023April 30, 2024

Bod announces A$2m capital raise as senior team takes pay cut

by Martin Lane November 8, 2023April 30, 2024

Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth

by Steve Jones and Martin Lane November 1, 2023November 6, 2023

Bod Science plots another capital raise as expanded product range set to launch

by Steve Jones October 31, 2023April 30, 2024

Cann Group doubles revenue but ASX again seeks reassurance over finances

by Steve Jones October 31, 2023April 30, 2024